TCL Archive In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End November 26, 1999
TCL Archive Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program June 24, 1977
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive 2013 Appropriations: Additional Level of Grant Review Proposed As NIH Prepares For Cost Cutting March 30, 2012
TCL Archive Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess” September 11, 1981
